1200009I06Rik Inhibitors
Chemical inhibitors of 1200009I06Rik encompass a variety of compounds that can modulate the activity of this protein through their action on different kinases and enzymes involved in signaling pathways. Wortmannin and LY294002 are two such inhibitors that target phosphoinositide 3-kinases (PI3K), an upstream regulator of AKT kinase. By inhibiting PI3K, these chemicals prevent the phosphorylation and subsequent activation of AKT, leading to a decrease in the phosphorylation state of downstream targets, including 1200009I06Rik. This inhibition halts the signaling cascade at an early stage, effectively reducing the activity of 1200009I06Rik. Another compound, Rapamycin, acts by binding to and inhibiting mTOR, a crucial kinase in the PI3K/AKT/mTOR pathway. The suppression of mTOR activity by Rapamycin leads to diminished downstream effects on cell growth and proliferation, which in turn affects proteins regulated by this pathway, such as 1200009I06Rik.
In addition to these, PD98059 and U0126 are inhibitors of MEK1/2 and by extension the MAPK/ERK pathway. Through the inhibition of MEK, these chemicals prevent the activation of ERK, a kinase that phosphorylates a wide array of substrate proteins. If 1200009I06Rik is a downstream target of ERK, its activity would be reduced as a result of this inhibition. SB203580 and PD169316 specifically inhibit p38 MAP kinase, a key player in the response to stress and cytokines. The activity of 1200009I06Rik, if regulated through p38-dependent pathways, would be affected by these inhibitors. SP600125, a JNK inhibitor, and PP2, a Src family kinase inhibitor, can also modulate the function of 1200009I06Rik by preventing the phosphorylation of substrates within their respective signaling networks. Lastly, Y-27632, Bisindolylmaleimide I, and Go6983 target ROCK, PKC, and multiple PKC isoforms, respectively. These inhibitors can alter signaling pathways related to cytoskeletal dynamics, gene expression, and cell proliferation, and therefore have the capacity to modulate the activity of 1200009I06Rik if it is influenced by these pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a steroidal metabolite of fungi which acts as a potent and irreversible inhibitor of phosphoinositide 3-kinases (PI3K). Since 1200009I06Rik is involved in the PI3K/AKT pathway, the inhibition of PI3K by Wortmannin will prevent AKT activation and subsequent phosphorylation of downstream targets, including 1200009I06Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a synthetic molecule that inhibits PI3K. Similar to Wortmannin, LY294002's inhibition of PI3K will halt the activation of AKT, leading to a decrease in the phosphorylation and activity of downstream proteins such as 1200009I06Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a macrolide compound that binds to and inhibits mTOR, a key kinase in the PI3K/AKT/mTOR pathway. The inhibition of mTOR will result in the suppression of downstream effectors involved in cell growth, proliferation, and survival, thereby reducing the activity of proteins like 1200009I06Rik that are regulated by this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is upstream of ERK in the MAPK/ERK pathway. By inhibiting MEK, PD98059 prevents the activation of ERK and thus the phosphorylation of ERK's substrate proteins, potentially including 1200009I06Rik, which may be involved in this signaling cascade. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, similar to PD98059, and it functions to inhibit the MAPK/ERK pathway. This results in the blockade of ERK-mediated signaling, which would inhibit the phosphorylation and activation of proteins such as 1200009I06Rik if they are downstream targets. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a pyridinyl imidazole derivative that selectively inhibits p38 MAP kinase. By inhibiting p38, SB203580 can disrupt signaling pathways that regulate cellular responses to stress and cytokines, potentially diminishing the activity of proteins like 1200009I06Rik that may be regulated by p38-dependent pathways. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
PD169316 is another inhibitor of p38 MAP kinase. It functions similarly to SB203580 in that it suppresses the p38 MAPK pathway and thereby could inhibit the activity of downstream proteins like 1200009I06Rik that are regulated through this stress-responsive signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an anthrapyrazolone inhibitor of c-Jun N-terminal kinase (JNK). Inhibition of JNK by SP600125 could prevent the phosphorylation of JNK substrates, potentially including proteins like 1200009I06Rik if they are part of the JNK signaling network. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family tyrosine kinases. Src kinases play roles in various signaling pathways, and their inhibition by PP2 could lead to reduced activity of proteins like 1200009I06Rik if they are regulated by Src-mediated phosphorylation events. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of Rho-associated protein kinase (ROCK). By inhibiting ROCK, Y-27632 can affect signaling pathways that regulate cytoskeletal dynamics, leading to the inhibition of downstream targets including proteins like 1200009I06Rik that may be influenced by ROCK activity. | ||||||